Neurostimulation Market

1. Executive Summary

2. Introduction
     2.1. Study Objectives
     2.2. Market Definition
          2.2.1. Market Covered
          2.2.2. Geographical Coverage
          2.2.3. Study Years & Currency
     2.3. Market Stakeholders
     2.4. Key Questions this Study will Answer
     2.5. GMI Research’s Approach & Methodology

3. Global Neurostimulation Market – Overview
     3.1. Introduction
     3.2. Market Segmentation
     3.3. Value Chain Analysis
     3.4. Drivers
     3.5. Restraints
     3.6. Trends

4. Global Neurostimulation Market Revenue Forecast till 2025

5. Global Neurostimulation Market by Product Type Revenue Forecast till 2025
     5.1. Implantable
          5.1.1. Deep Brain Stimulators
          5.1.2. Sacral Nerve Stimulator
          5.1.3. Spinal Cord Stimulators
          5.1.4. Vagus Nerve Stimulators
          5.1.5. Others
     5.2. Non-implantable
          5.2.1. Transcranial Magnetic Stimulation (TMS)
          5.2.2. Transcutaneous Electrical Nerve stimulation (TENS)

6. Global Neurostimulation Market by Indication Revenue Forecast till 2025
     6.1. Chronic pain
     6.2. Movement disorders
     6.3. Epilepsy
     6.4. Others

7. Global Neurostimulation Market by End User Revenue Forecast till 2025
     7.1. Hospitals
     7.2. Ambulatory Surgical Centers
     7.3. Specialty Clinics

8. Global Neurostimulation Market by Geography Revenue Forecast till 2025
     8.1. North America Neurostimulation Market Revenue Forecast till 2025
          8.1.1. North America Neurostimulation Market by Product Type (Option 1: 25% customization)
                    8.1.1.1. Implantable
                           8.1.1.1.1. Deep Brain Stimulators
                           8.1.1.1.2. Sacral Nerve Stimulator
                           8.1.1.1.3. Spinal Cord Stimulators
                           8.1.1.1.4. Vagus Nerve Stimulators
                           8.1.1.1.5. Others

                    8.1.1.2. Non-implantable
                           8.1.1.2.1. Transcranial Magnetic Stimulation (TMS)
                           8.1.1.2.2. Transcutaneous Electrical Nerve stimulation (TENS)

          8.1.2. North America Neurostimulation Market by Indication
                    8.1.2.1. Chronic pain
                    8.1.2.2. Movement disorders
                    8.1.2.3. Epilepsy
                    8.1.2.4. Others

          8.1.3. North America Neurostimulation Market by End User
                    8.1.3.1. Hospitals
                    8.1.3.2. Ambulatory Surgical Centers
                    8.1.3.3. Specialty Clinics

     8.2. Europe Neurostimulation Market Revenue Forecast till 2025
          8.2.1. Europe Neurostimulation Market by Product Type (Option 2: 25% customization)
                    8.2.1.1. Implantable
                           8.2.1.1.1. Deep Brain Stimulators
                           8.2.1.1.2. Sacral Nerve Stimulator
                           8.2.1.1.3. Spinal Cord Stimulators
                           8.2.1.1.4. Vagus Nerve Stimulators
                           8.2.1.1.5. Others
                    8.2.1.2. Non-implantable
                           8.2.1.2.1. Transcranial Magnetic Stimulation (TMS)
                           8.2.1.2.2. Transcutaneous Electrical Nerve stimulation (TENS)

          8.2.2. Europe Neurostimulation Market by Indication
                    8.2.2.1. Chronic pain
                    8.2.2.2. Movement disorders
                    8.2.2.3. Epilepsy
                    8.2.2.4. Others

          8.2.3. Europe Neurostimulation Market by End User
                    8.2.3.1. Hospitals
                    8.2.3.2. Ambulatory Surgical Centers
                    8.2.3.3. Specialty Clinics

     8.3. Asia-Pacific Neurostimulation Market Revenue Forecast till 2025
                    8.3.1. Asia-Pacific Neurostimulation Market by Product Type (Option 3: 25% customization)
                    8.3.1.1. Implantable
                           8.3.1.1.1. Deep Brain Stimulators
                           8.3.1.1.2. Sacral Nerve Stimulator
                           8.3.1.1.3. Spinal Cord Stimulators
                           8.3.1.1.4. Vagus Nerve Stimulators
                           8.3.1.1.5. Others

                    8.3.1.2. Non-implantable
                           8.3.1.2.1. Transcranial Magnetic Stimulation (TMS)
                           8.3.1.2.2. Transcutaneous Electrical Nerve stimulation (TENS)

          8.3.2. Asia-Pacific Neurostimulation Market by Indication
                    8.3.2.1. Chronic pain
                    8.3.2.2. Movement disorders
                    8.3.2.3. Epilepsy
                    8.3.2.4. Others

          8.3.3. Asia-Pacific Neurostimulation Market by End User
                    8.3.3.1. Hospitals
                    8.3.3.2. Ambulatory Surgical Centers
                    8.3.3.3. Specialty Clinics

     8.4. Rest of the World Neurostimulation Market Revenue Forecast till 2025
          8.4.1. Rest of the World Neurostimulation Market by Product Type (Option 4: 25% customization)
                    8.4.1.1. Implantable
                           8.4.1.1.1. Deep Brain Stimulators
                           8.4.1.1.2. Sacral Nerve Stimulator
                           8.4.1.1.3. Spinal Cord Stimulators
                           8.4.1.1.4. Vagus Nerve Stimulators
                           8.4.1.1.5. Others
                    8.4.1.2. Non-implantable
                           8.4.1.2.1. Transcranial Magnetic Stimulation (TMS)
                           8.4.1.2.2. Transcutaneous Electrical Nerve stimulation (TENS)

          8.4.2. Rest of the World Neurostimulation Market by Indication
                    8.4.2.1. Chronic pain
                    8.4.2.2. Movement disorders
                    8.4.2.3. Epilepsy
                    8.4.2.4. Others

          8.4.3. Rest of the World Neurostimulation Market by End User
                    8.4.3.1. Hospitals
                    8.4.3.2. Ambulatory Surgical Centers
                    8.4.3.3. Specialty Clinics

9. Competitive Landscape
     9.1. Porter 5 Analysis
     9.2. Major players and their key strategies
     9.3. Company Share Analysis

10. Company Profiles (Option 5: 25% Customization – Profiles of 5 Additional Companies of your Choice)
       10.1. Medtronic plc
            10.1.1. Company Overview
            10.1.2. Financials
            10.1.3. Recent Developments

       10.2. Cyberonics Inc.
            10.2.1. Company Overview
            10.2.2. Financials
            10.2.3. Recent Developments

       10.3. NeuroPace, Inc.
            10.3.1. Company Overview
            10.3.2. Financials
            10.3.3. Recent Developments

       10.4. NeuroSigma, Inc.
            10.4.1. Company Overview
            10.4.2. Financials
            10.4.3. Recent Developments

       10.5. Nevro Corp.
            10.5.1. Company Overview
            10.5.2. Financials
            10.5.3. Recent Developments

       10.6. Depuy Synthes
            10.6.1. Company Overview
            10.6.2. Financials
            10.6.3. Recent Developments

       10.7. Synapse Biomedical Inc.
            10.7.1. Company Overview
            10.7.2. Financials
            10.7.3. Recent Developments

       10.8. Boston Scientific Corporation
            10.8.1. Company Overview
            10.8.2. Financials
            10.8.3. Recent Developments

       10.9. Bayer Corporation
            10.9.1. Company Overview
            10.9.2. Financials
            10.9.3. Recent Developments

       10.10. BioControl Medical
            10.10.1. Company Overview
            10.10.2. Financials
            10.10.3. Recent Developments

11. About GMI Research